Warp Speed Lives Up To Its Name: FDA Planning Late October Vaccine Advisory Committee

05 Aug 2020

Preliminary plans for an Oct. 22 meeting of US FDA's vaccine advisory committee suggest a fast evaluation of COVID-19 immunizations, bringing mixed reactions from onlookers who say it could be a positive sign of needed public transparency or an indication the agency is rushing to approve a product ahead of the November presidential election.

Covid19_Vaccine_Vial — COVID-19 vaccines may be the subject of an October FDA advisory committee • Source: Shutterstock

Warp Speed Lives Up To Its Name: FDA Planning Late October Vaccine Advisory Committee

More from US FDA

More from Agency Leadership